omeprazole and valinomycin

omeprazole has been researched along with valinomycin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19905 (55.56)18.7374
1990's2 (22.22)18.2507
2000's0 (0.00)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ1
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Hersey, SJ; Matheravidathu, S; Sachs, G; Steiner, L1
Asano, S; Iino, T; Tabuchi, Y; Takeguchi, N1
Blakeman, DP; Im, WB; McGrath, JP; Sih, JC1
Jackson, R; Lorentzon, P; Sachs, G; Wallmark, B1
Fallowfield, C; Keeling, DJ; Underwood, AH1
Bender, AS; White, HS; Woodbury, DM1
Andersson, K; Bayati, A; Lee, H; Lorentzon, P1

Other Studies

9 other study(ies) available for omeprazole and valinomycin

ArticleYear
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2010, Volume: 118, Issue:2

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics

2010
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Gastric H+-K+-ATPase in situ: relation to secretory state.
    The American journal of physiology, 1988, Volume: 254, Issue:6 Pt 1

    Topics: 4-Nitrophenylphosphatase; Adenosine Triphosphatases; Animals; Digitonin; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Imidazoles; Male; Nigericin; Omeprazole; Permeability; Rabbits; Valinomycin

1988
Properties of light and heavy vesicles simultaneously prepared from hog gastric mucosae.
    Journal of biochemistry, 1988, Volume: 103, Issue:4

    Topics: Adenosine Triphosphatases; Animals; Antibodies, Monoclonal; Cell Fractionation; Electrophoresis, Polyacrylamide Gel; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Imidazoles; Immunochemistry; Omeprazole; Potassium Chloride; Subcellular Fractions; Swine; Valinomycin

1988
Omeprazole, a specific inhibitor of gastric (H+-K+)-ATPase, is a H+-activated oxidizing agent of sulfhydryl groups.
    The Journal of biological chemistry, 1985, Apr-25, Volume: 260, Issue:8

    Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Aminopyrine; Animals; Benzimidazoles; Cell Membrane; Dose-Response Relationship, Drug; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Kinetics; Magnetic Resonance Spectroscopy; Male; Omeprazole; Potassium Chloride; Protons; Sulfhydryl Compounds; Swine; Valinomycin

1985
Inhibition of (H+ + K+)-ATPase by omeprazole in isolated gastric vesicles requires proton transport.
    Biochimica et biophysica acta, 1987, Feb-12, Volume: 897, Issue:1

    Topics: 4-Nitrophenylphosphatase; Acridine Orange; Adenosine Triphosphatases; Ammonium Chloride; Animals; Biological Transport, Active; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Mercaptoethanol; Omeprazole; Potassium; Protein Binding; Protons; Stomach; Swine; Valinomycin

1987
The specificity of omeprazole as an (H+ + K+)-ATPase inhibitor depends upon the means of its activation.
    Biochemical pharmacology, 1987, Feb-01, Volume: 36, Issue:3

    Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Biotransformation; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Hydrogen-Ion Concentration; Omeprazole; Phosphorylation; Valinomycin

1987
Ionic dependence of adenosine uptake into cultured astrocytes.
    Brain research, 1994, Oct-24, Volume: 661, Issue:1-2

    Topics: Adenosine; Animals; Animals, Newborn; Astrocytes; Benzopyrans; Biological Transport; Calcimycin; Calcium; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cells, Cultured; Cerebral Cortex; Cromakalim; Furosemide; Glyburide; Ionophores; Kinetics; Mice; Niacinamide; Nicorandil; Nigericin; Omeprazole; Potassium; Pyrroles; Sodium; Valinomycin; Vasodilator Agents

1994
Selective inhibition of the gastric H+,K(+)-ATPase by omeprazole and related compounds.
    Annals of the New York Academy of Sciences, 1997, Nov-03, Volume: 834

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Benzimidazoles; Binding Sites; Enzyme Inhibitors; Gastric Mucosa; H(+)-K(+)-Exchanging ATPase; Humans; Kinetics; Lansoprazole; Omeprazole; Pantoprazole; Proton Pump Inhibitors; Rabeprazole; Structure-Activity Relationship; Sulfoxides; Valinomycin

1997